Pleural Catheters Market

Pleural Catheters Market Outlook (2022-2032)

The global pleural catheters market has reached a valuation of US$ 28.2 million in 2022 and is expected to expand at a CAGR of 6.6% to end up at US$ 53.3 million by 2032.

Europe is predicted to account for 23.6% share of the global market by the end of 2032.

Report Attributes	Details
Pleural Catheters Market Size (2021A)	US$ 26.6 Million
Estimated Market Value (2022E)	US$ 28.2 Million
Forecasted Market Value (2032F)	US$ 53.3 Million
Global Market Growth Rate (2022-2032)	6.6 % CAGR
North America Market Share (2021)	~ 39.1%
Europe Market Growth Rate (2022-2032)	~ 5.9% CAGR
United States Market Growth Rate (2022-2032)	~7.5% CAGR
Market Share of Top 5 Companies	~ 42.8%
Key Companies Profiled	Rocket Medical plc. Merit Medical Systems, Inc. BD B. Braun Melsungen Eakin Healthcare Group

Sales Analysis of Pleural Catheters (2017-2021) Vs. Market Forecasts (2022-2032)

Malignant Pleural Effusions (MPE) have been one of the most common and serious conditions among the population. An effort towards reducing recurrent MPE has motivated the manufacturers to develop pleural catheters with increased efficiency. Demand for pleural catheters from healthcare professionals is further propelling the growth of the market. The combined use of pleural catheters in hospitals and ASCs increased by a compound annual growth rate of 5.2% from 2017 to 2021. Increasing awareness about the consequences of MPE and the need for early diagnosis will drive the growth of the pleural catheters market.

The aim of providing palliative care to the patients while minimizing the adverse effects is promoting the development of more efficient & non-invasive processes, which is driving several government and healthcare organization initiatives regarding the treatment and diagnosis accelerating the growth of the pleural catheters market over the forecast period.

Fact.MR predicts that the global pleural catheters market will be valued at US$ 53.3 million by 2032-end, expanding at a CAGR of 6.6% over the next ten years.

• Short Term (2022 Q2 to 2025): Utilization of pleural catheters for the management of malignant pleural effusions is expected to mark an increase in the market during the short term.
• Medium Term (2025-2028): Pleural catheters, being a less invasive and convenient choice for MPE, will see increased adoption by pulmonologists and physicians.
• Long Term (2028-2032): Presence of leading market players in the healthcare sector will dictate the long-term growth of the pleural catheters market across the globe.

From 2017 to 2021, the global pleural catheters market registered a CAGR of 5.2%, and according to Fact.MR, a market research and competitive intelligence provider, the market is projected to exhibit growth at 6.6% CAGR between 2022 and 2032.

Market share analysis of pleural catheters based on indication and region. Under the indication segment, the malignant pleural effusions segment dominates with 74.3% market share in 2022.

What’s Majorly Driving Demand for Pleural Catheters?

“Growing Worldwide Incidence of Cardiac Infarction”

Changing sedentary lifestyles and consumption of processed food leads to an upsurge in the risk of congestive heart failure, which requires standardized systems for diagnosis and treatment, spurring the market growth for pleural catheters. In addition, the aging and elderly population are more sensitive to cardiovascular diseases, which is also considered one of the key factors supporting the increasing demand for pleural catheters.

Apart from this, growing awareness among the population with regards to the use of pleural catheters for the management of pleural effusions during heart failure also supports the growth of the pleural catheters market. The aforementioned reasons help to maintain the growth trajectory of the pleural catheters market.

“Increasing Adoption of Non-invasive Procedures in Healthcare”

Technology advances incorporated in the healthcare sector are being harnessed for disease treatment and supportive care. Increasing pervasiveness of the internet, social media platforms for addressing health-related information, etc. have given an opportunity for the population to introduce them to new technological advancements in the medical industry.

In addition, there is an increasing demand for minimally invasive processes from the aging population who majorly suffer from cardiovascular diseases. Less associated risks with the use of pleural catheters and the ease of using them for patient outcomes are driving their demand among healthcare professionals across the globe.

Rise in the research and development sector for the introduction of new products into the market according to end users’ requirements has spurred the demand for pleural catheters. This increase in demand for non-invasive technological advancements from the target population will be directly proportional to market expansion.

What Do Pleural Catheter Producers Need to Watch Out For?

“Complications Associated with Product Use”

Pleural catheters are widely used for patients with recurrent heart-related chronic diseases. Although they are simple to place without providing any sedation to the patients, there are various complications associated with their use.

Catheter-related pleural infections are most commonly seen among patients. In addition, catheter tract metastases, severe chest pain, dislocation of the tube, etc., are some other risks associated with the use of pleural catheters in patients. Such complications related to the long-term presence of pleural catheters in the body can cause trouble to patients, thereby hindering market expansion.

Country-wise Insights

Why is the U.S. a Major Market for Pleural Catheters?

The United States pleural catheters market is estimated at US$ 10.4 million in 2022.

The United States has one of the world's most well-established healthcare sector, which will have a positive impact on the market in the country. The growing population suffering from cardiovascular diseases is said to increase the demand for pleural catheters. In addition, easy access to healthcare facilities, insurance coverage, and reimbursement policies are some of the other factors that contribute to the dominance of the U.S.

Growing research and development programs by manufacturers for the healthcare sector are likely to create a lot of opportunities for pleural catheter suppliers in the near future.

Why are the U.K, Germany, and Italy Highly Lucrative Markets?

Europe accounted for 25.1% share of the global pleural catheters market at the end of 2021.

Shift in consumers’ desire towards the use of non-invasive procedures for treatment and preventive care has motivated manufacturers to develop new products. With strict regulatory approvals from government organizations, quality products are being developed by the healthcare market players thereby increasing their customer base. In addition, the rising prevalence of COPD as well as the expansion of hospitals throughout the region creates a highly lucrative market for pleural catheters in Europe.

The U.K, Germany, and Italy markets for pleural catheters are expected to grow at CAGRs of 6.3%, 7.3%, and 5.8%, respectively, between 2022 and 2032.

Category-wise Insights

Why Do Malignant Pleural Effusions Account for High Revenue Generation?

Under indication, the market is categorized into malignant pleural effusions, non-malignant recurrent effusions, chylothorax, empyema, and haemothorax. Amongst them, malignant pleural effusions hold the largest market share of 74.2% in 2021 and the segment is projected to witness a CAGR of 7% during the forecast years of 2022-2032.

This dominance is due to the common prevailing complications of advanced malignancy that results in cough or chest tightness. It is also widely used to investigate the origin of cancer. In addition, pulmonologists and other healthcare professionals have considered pleural catheters as a standard choice for the palliative care of malignant pleural effusions.

Will the Use of Pleural Catheters Rise Further in Hospitals?

Today, sales of pleural catheters for various indications are increasing rapidly. The prevalence of pleural effusions among the population is increasing thereby increasing the hospitalization rate. The opportunity to treat and prevent cardiovascular diseases amongst the population will drive the demand for pleural catheters throughout the globe.

The use of pleural catheters by hospitals is anticipated to create an absolute $ opportunity of US$ 19.1 million by the end of the assessment period of 2022- 2032.

Competitive Landscape

Prominent pleural catheter manufacturers are Rocket Medical plc., Merit Medical Systems, Inc., Becton, Dickinson and Company, B. Braun Melsungen, and Eakin Healthcare Group.

Rising prevalence of chronic diseases is the major factor that is driving manufacturers to develop pleural catheter products. Key suppliers of pleural catheter products are incorporating innovative technologies and optimization systems in their product lines according to end usability.

• In Dec 2020, Eakin Healthcare Group acquired Armstrong Medical, a firm that makes respiratory products, to expand its product line into a new therapeutic area.

Fact.MR has provided detailed information about the price points of key manufacturers of pleural catheters positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.

Segmentation of Pleural Catheters Industry Research

• By Indication :

  • Malignant Pleural Effusions
  • Non-Malignant Recurrent Effusions
  • Chylothorax
  • Empyema
  • Haemothorax

• By End User :

  • Hospitals
  • Ambulatory Surgical Centers

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA